Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEsure Group Regulatory News (ESUR)

  • There is currently no data for ESUR

Form 8.3 - ESURE GROUP PLC

9 Nov 2018 11:51

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose ESURE GROUP PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 08 November 2018
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 0.08333p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 7,619,862 1.82% 77,664 0.02%
(2) Cash-settled derivatives:
30,905 0.01% 7,122,768 1.70%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 7,650,767 1.82% 7,200,432 1.72%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
0.08333p ordinary Purchase 5,525 2.7958 GBP
0.08333p ordinary Purchase 9,806 2.7920 GBP
0.08333p ordinary Purchase 10,111 2.7960 GBP
0.08333p ordinary Purchase 41,005 2.7956 GBP
0.08333p ordinary Sale 940 2.7960 GBP
0.08333p ordinary Sale 1,986 2.7940 GBP
0.08333p ordinary Sale 2,791 2.7957 GBP
0.08333p ordinary Sale 6,007 2.7959 GBP
0.08333p ordinary Sale 9,805 2.7920 GBP
0.08333p ordinary Sale 12,547 2.7935 GBP
0.08333p ordinary Sale 32,913 2.7958 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
0.08333p ordinary SWAP Long 97 2.7940 GBP
0.08333p ordinary SWAP Long 814 2.7951 GBP
0.08333p ordinary CFD Long 988 2.7935 GBP
0.08333p ordinary SWAP Long 9,752 2.7960 GBP
0.08333p ordinary CFD Long 19,130 2.7957 GBP
0.08333p ordinary CFD Long 20,136 2.7936 GBP
0.08333p ordinary SWAP Short 1 2.7900 GBP
0.08333p ordinary CFD Short 10,111 2.7960 GBP
0.08333p ordinary CFD Short 41,005 2.7956 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 9 Nov 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181109005220/en/

Copyright Business Wire 2018

Date   Source Headline
14th Aug 20183:20 pmRNSForm 8.3 - eSure Group plc
14th Aug 20183:20 pmRNSForm 8.3 - esure Group plc
14th Aug 20183:13 pmRNSForm 8.3 - esure Group plc
14th Aug 20183:01 pmRNSForm 8.3 - Esure Group Inc
14th Aug 20181:59 pmRNSForm 8.3 - [esure Group plc]
14th Aug 20181:48 pmRNSForm 8.3 - esure Group plc
14th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - esure Group Plc
14th Aug 201811:33 amRNSForm 8.5 (EPT/RI) Esure Group Plc
14th Aug 201811:03 amPRNForm 8.3 - ESURE GROUP PLC
14th Aug 201810:32 amRNSForm 8.5 (EPT/RI)
14th Aug 20189:19 amPRNForm 8.3 - esure Group PLC
14th Aug 20187:00 amRNSOffer by Blue (BC) Bidco Limited
14th Aug 20187:00 amRNS2018 Interim results and proposed acquisition
13th Aug 201811:01 amRNSPossible Offer
4th Jul 201811:03 amRNSHolding(s) in Company
3rd Jul 20188:20 amRNSTotal Voting Rights
28th Jun 201812:25 pmRNSDirectorate Change
8th Jun 20183:08 pmRNSHolding(s) in Company
1st Jun 20189:12 amRNSTotal Voting Rights
18th May 20184:36 pmRNSAGM Results
4th May 20189:16 amRNS2017 Solvency & Financial Condition Report
3rd May 20187:00 amRNS2018 Q1 Trading Update
1st May 20183:42 pmRNSTotal Voting Rights
16th Apr 20184:28 pmRNSHolding(s) in Company
13th Apr 20182:55 pmRNSNotice of Annual General Meeting and Annual Report
3rd Apr 20183:15 pmRNSBlock listing Interim Review
3rd Apr 20183:09 pmRNSTotal Voting Rights
28th Mar 20188:00 amRNSDirector/PDMR Shareholding
21st Mar 20183:58 pmRNSDirector/PDMR Shareholding
21st Mar 20183:53 pmRNSDirector/PDMR Shareholding
21st Mar 20183:52 pmRNSDirector/PDMR Shareholding
8th Mar 20183:00 pmRNSAdditional Listing
7th Mar 20187:00 amRNS2017 Preliminary results
1st Mar 20189:59 amRNSTotal Voting Rights
28th Feb 20189:06 amRNSDirectorate Change
20th Feb 20188:23 amRNSNotice of Results
1st Feb 201810:04 amRNSTotal Voting Rights
19th Jan 20187:00 amRNSDirectorate Change & Trading Update
2nd Jan 20183:27 pmRNSTotal Voting Rights
1st Dec 20173:59 pmRNSTotal Voting Rights
8th Nov 20177:00 amRNS2017 Q3 Trading Update
2nd Nov 201712:43 pmRNSNotice of 2017 Q3 Trading Update
1st Nov 20179:24 amRNSTotal Voting Rights
10th Oct 20172:41 pmRNSHolding(s) in Company
10th Oct 201711:21 amRNSHolding(s) in Company
3rd Oct 20172:59 pmRNSAdditional Listing
2nd Oct 20179:53 amRNSBlock listing Interim Review
2nd Oct 20179:42 amRNSTotal Voting Rights
23rd Aug 20179:56 amRNSDirector Declaration
3rd Aug 20177:00 amRNS2017 Interim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.